Phreesia Insider Converts Restricted Stock Units Worth $77,500 in Planned Sale

Rhea-AI Filing Summary

Form 144 Notice of Proposed Sale filed for Phreesia (NYSE: PHR) indicates an insider's intent to sell 2,802 shares of common stock with an aggregate market value of $77,531.34. The sale is planned for execution on June 26, 2025 through Fidelity Brokerage Services.

Key transaction details:

• Shares were acquired through restricted stock vesting on June 25, 2025
• Acquisition was compensation-based from the issuer
• Current total shares outstanding: 59,504,269
• No other securities were sold by the insider in the past 3 months

This Form 144 represents a relatively small transaction relative to the company's total outstanding shares (approximately 0.0047%). The filing indicates the insider has confirmed having no knowledge of undisclosed material adverse information regarding the company's operations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2025 - 09:39 AM Learn about SEC filing dates

FAQ

How many shares of PHR stock are being sold according to the Form 144 filed on June 28, 2025?

According to the Form 144 filing, 2,802 shares of PHR common stock are proposed to be sold through Fidelity Brokerage Services LLC.

What is the aggregate market value of PHR shares being sold in this Form 144?

The aggregate market value of the shares to be sold is $77,531.34, as reported in the Form 144 filing.

How did the PHR insider acquire the shares being sold?

The shares were acquired through Restricted Stock Vesting from the issuer (Phreesia) on June 25, 2025 as part of compensation.

What is the total number of PHR shares outstanding according to the Form 144?

According to the Form 144 filing, Phreesia (PHR) has 59,504,269 shares outstanding.

When is the approximate date of sale for the PHR shares mentioned in the Form 144?

The approximate date of sale for the PHR shares is listed as June 26, 2025, to be executed through the NYSE.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2802	77531.34	59504269	06/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/25/2025	Restricted Stock Vesting	Issuer			2802	06/25/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)